# Kura Oncology, Inc. (KURA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/KURA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 18.27M | $ -73.33M | $ -85.98M | $ 14.52M | $ 107.88M |
| 2025 | $ 69.10M | $ -285.33M | $ -72.39M | $ 20.46M | $ 174.14M |
| 2024 | $ 56.64M | $ -182.87M | $ 140.68M | $ 16.59M | $ 413.64M |
| 2023 | $ 0 | $ -165.03M | $ -135.15M | $ 17.20M | $ 397.27M |
| 2022 | $ 0 | $ -151.75M | $ -123.65M | $ 14.02M | $ 420.28M |
| 2021 | $ 0 | $ -155.08M | $ -125.64M | $ 6.88M | $ 506.61M |
| 2020 | $ 0 | $ -114.18M | $ -91.72M | $ 14.98M | $ 610.91M |
| 2019 | $ 0 | $ -81.50M | $ -70.68M | $ 7.75M | $ 218.78M |
| 2018 | $ 3.22M | $ -79.83M | $ -64.26M | $ 7.50M | $ 160.99M |
| 2017 | $ 0 | $ -47.73M | $ -38.31M | $ 7.10M | $ 79.87M |
| 2016 | $ 0 | $ -37.92M | $ -34.88M | $ 7.32M | $ 56.88M |
| 2015 | $ 0 | $ -31.77M | $ -25.26M | $ 0 | $ 82.10M |
| 2014 | $ 0 | $ -124.6K | $ -68.6K | $ 250.0K | $ -154.7K |
| 2013 | $ 0 | $ -38.8K | $ -34.7K | $ 220.0K | $ -124.0K |
| 2012 | $ 0 | $ -39.0K | $ -32.7K | $ 170.0K | $ -95.3K |
| 2011 | $ 0 | $ -40.5K | $ -31.6K | $ 120.0K | $ -68.0K |
| 2010 | $ 0 | $ -33.9K | $ -24.6K | $ 60.0K | $ -41.0K |
| 2009 | $ 0 | $ -30.3K | $ -4.1K | $ 25.0K | $ -11.1K |
| 2008 | $ 0 | $ -50.9K | $ -48.1K | $ 0 | $ 1.4K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.13 |
| Liabilities / Eq | 5.05 |
| Current Ratio | 6.15 |

## Other views

- [Metrics](https://sponda.capital/en/KURA.md)
- [Charts](https://sponda.capital/en/KURA/charts.md)
- [Compare](https://sponda.capital/en/KURA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.